SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-155765
Filing Date
2019-05-24
Accepted
2019-05-23 21:21:03
Documents
3
Group Members
AARON I. DAVISBOXER ASSET MANAGEMENT INC.BRASLYN LTD.CHRISTOPHER FUGLESANGIVAN M. LIEBERBURGJOE LEWISMVA INVESTORS, LLCNEIL REISMANSHEHAN B. DISSANAYAKE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d744578dsc13da.htm SC 13D/A 195173
2 EX-99.1 d744578dex991.htm EX-99.1 11668
3 EX-99.4 d744578dex994.htm EX-99.4 5285
  Complete submission text file 0001193125-19-155765.txt   213936
Mailing Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130 (858) 400-3112
Boxer Capital, LLC (Filed by) CIK: 0001465837 (see all company filings)

IRS No.: 203828456 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Subject) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87670 | Film No.: 19851909
SIC: 2834 Pharmaceutical Preparations